alendronate and Cardiomyopathies studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research Excerpts

Excerpt	Relevance	Reference
" The objective of this study was to determine whether the osteoporosis treatment agent alendronate accelerates the rate of CAC."	7.71	Progression of coronary artery calcification in patients taking alendronate for osteoporosis. ( Adams, JS; Aziz, D; Emerick, AM; Gjertson, D; Goldin, JG; Greaser, LD; Hill, JA; Khorrami, S; Yoon, HC, 2002)
" The objective of this study was to determine whether the osteoporosis treatment agent alendronate accelerates the rate of CAC."	3.71	Progression of coronary artery calcification in patients taking alendronate for osteoporosis. ( Adams, JS; Aziz, D; Emerick, AM; Gjertson, D; Goldin, JG; Greaser, LD; Hill, JA; Khorrami, S; Yoon, HC, 2002)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

alendronate and Cardiomyopathies

Research Excerpts

Research

Studies (1)

Authors

Other Studies

Authors	Studies
Hill, JA	1
Goldin, JG	1
Gjertson, D	1
Emerick, AM	1
Greaser, LD	1
Yoon, HC	1
Khorrami, S	1
Aziz, D	1
Adams, JS	1